Low Dose Naltrexone UK: a complete guide to benefits and access

Low dose naltrexone (LDN) is a bit of a medical marvel. It’s the same medicine used to help with addiction, just given at a tiny fraction of the usual strength—often around 1/10th of the standard amount. It’s used ‘off label’ to help manage a range of chronic conditions, particularly those involving pain and immune system imbalances. The clever part is how it works: LDN temporarily blocks your body’s endorphin receptors, which gently prompts your system to produce more of its own natural pain-relieving and anti-inflammatory chemicals.

Low Dose Naltrexone UK: A complete guide to benefits and access- An introduction

Low dose naltrexone (LDN) is a bit of a medical marvel. It’s the same medicine used to help with addiction, just given at a tiny fraction of the usual strength—often around 1/10th of the standard amount. It’s used ‘off label’ to help manage a range of chronic conditions, particularly those involving pain and immune system imbalances. The clever part is how it works: LDN temporarily blocks your body’s endorphin receptors, which gently prompts your system to produce more of its own natural pain-relieving and anti-inflammatory chemicals.

Five key takeaways

1. LDN works through a clever biological “rebound effect”. By briefly blocking opioid receptors at low doses (0.5–4.5mg), LDN triggers your body to produce more endorphins and anti-inflammatory chemicals. It’s not a full blockade like high-dose naltrexone; it’s a gentle nudge that encourages your system to heal itself from within.

2. It tackles both pain and inflammation simultaneously. LDN doesn’t just mask symptoms. It boosts natural pain-relieving endorphins while also calming overactive microglial cells in the brain and spinal cord, reducing the neuroinflammation that drives conditions like fibromyalgia, ME/CFS, and long COVID.

3. The evidence is strong, but access remains limited. Clinical studies show consistent benefits—particularly for fibromyalgia—with an excellent safety profile. However, because naltrexone is off-patent, pharmaceutical companies have no financial incentive to fund large trials, leaving LDN as an off-label treatment that many GPs feel hesitant to prescribe.

4. “Start low, go slow” is the golden rule. LDN requires careful titration, beginning at 0.5–1.5mg and gradually increasing over weeks. This patient approach allows your body to adapt comfortably and helps your clinician find your personal “sweet spot” dose, typically around 4.5mg.

5. Private specialists and compounding pharmacies bridge the NHS gap. Because standard naltrexone comes in 50mg tablets (far too high for LDN), you need a compounding pharmacy to create precise, custom-dosed capsules. Private clinicians like those at Medical Mojo offer a faster, more expert route to access this emerging treatment safely.

What this guide covers

This complete guide walks you through LDN from the ground up: how it works at the cellular level, which conditions benefit most, what the research actually says, how to navigate dosing and side effects, and—most importantly—how to access it safely in the UK. Whether you’re exploring LDN for fibromyalgia, ME/CFS, long COVID, or an autoimmune condition, you’ll find the practical, evidence-based information you need to make an informed decision with your clinician.

Unlocking a new purpose from an old medicine

It’s a curious tale of medical discovery when a drug designed for one thing finds a completely new life somewhere else. Naltrexone was first approved back in the 1980s at a standard dose of 50–100mg to help people with opioid and alcohol dependence. At this higher dose, it puts a full, long-lasting block on opioid receptors, which stops substances like heroin or alcohol from creating a euphoric effect.

But then researchers stumbled upon something remarkable. When used at a much, much smaller dose—typically between 0.5mg and 4.5mg—naltrexone behaves very differently. This is what we now call low dose naltrexone, or LDN. Instead of a complete blockade, LDN provides a brief, gentle interruption to the body’s opioid receptor activity.

The rebound effect: a clever biological trick

Think of it like this: imagine you briefly hold a door shut against someone trying to get in. As soon as you let go, they’re likely to push through with more force than before. LDN does something similar inside your body. By temporarily blocking the landing spots for your natural ‘feel-good’ chemicals (endorphins), it tricks your body into thinking it’s not producing enough of them.

This short blockade sends a signal to ramp up production. The result is a ‘rebound effect’ where your body makes more endorphins and enkephalins than it normally would. These are your body’s own powerful tools for:

• Pain relief: Endorphins are often called the body’s natural painkillers.
• Mood regulation: They play a big part in feelings of well-being and happiness.
• Immune system balance: They have a key role in calming inflammation and guiding immune cell function. You can learn more about the fascinating connection between the immune system and endogenous opioids in our dedicated guide.

Taming inflammation and rebalancing the immune system

Boosting endorphins is only half the story. Low dose naltrexone has another crucial effect: it helps to calm down overactive immune cells in the brain and spinal cord called microglia. When these cells get stuck in a chronically activated state, they pump out inflammatory substances that contribute to symptoms like widespread pain, crushing fatigue, and ‘brain fog’—all common complaints in conditions like fibromyalgia and long COVID.

By soothing these microglial cells, LDN helps to turn down the volume on chronic inflammation. It doesn’t switch the immune system off; instead, it acts as a modulator, gently encouraging it to return to a state of balance.

This dual action—boosting endorphins while also reducing neuroinflammation—is why LDN has gained so much attention as a promising off-label treatment. It doesn’t just mask a single symptom. Instead, it helps to re-regulate the underlying systems that have gone haywire. For many people managing complex chronic conditions, this approach offers a new glimmer of hope, providing a gentle yet effective way to help the body heal itself from within.

Where low dose naltrexone really shines

Now that we’ve pulled back the curtain on the clever biological trick behind low dose naltrexone, let’s look at the conditions where it’s making a real difference. LDN is most often considered for chronic illnesses where the immune system has gone haywire, and inflammation is a key troublemaker.

These are often the very conditions that leave people feeling stuck, having tried countless other options without success.

Instead of just chasing a single symptom, LDN offers a different kind of hope by helping to rebalance the body’s own control systems. It gets to the root of what fuels widespread pain, profound fatigue, and that frustrating cognitive fog. Let’s dive into some of the main areas where LDN is changing lives.

Fibromyalgia and widespread pain

Fibromyalgia is a classic example of a condition where LDN’s unique actions hit the nail on the head. People with fibromyalgia live with a nervous system on high alert, amplifying pain signals to an unbearable degree. This is often paired with debilitating fatigue, poor sleep, and cognitive struggles.

LDN tackles this from two angles. First, by giving the body’s natural endorphins a boost, it helps to dial down pain perception. Second, it calms overactive microglial cells in the brain and spinal cord, reducing the neuroinflammation that many experts believe drives fibromyalgia symptoms.

This dual approach helps soothe the entire system, rather than just papering over the cracks. If you’re managing this condition, you might find our deep dive into the evidence for low dose naltrexone use in fibromyalgia particularly useful.

Chronic fatigue syndrome (ME/CFS) and long COVID

The overlap between ME/CFS and long COVID is impossible to ignore, with countless people experiencing post-viral symptoms that look remarkably similar. These conditions are defined by a severe, persistent fatigue that rest doesn’t touch, alongside post-exertional malaise (a ‘crash’ after even minimal activity), pain, and brain fog.

This is another area where LDN’s immune-modulating effects are showing real promise. The thinking is that it helps restore balance to an immune system thrown off course by a viral invader, calming the chronic, low-grade inflammation that keeps these symptoms going.

Chronic fatigue syndrome (ME/CFS) is a major health issue in the UK, affecting over 250,000 people. Early data from UK clinics suggests low dose naltrexone could offer genuine relief. A retrospective analysis found that 73.9% of patients reported improvements in energy, sleep, or concentration after starting LDN [1].

Autoimmune disorders

In autoimmune conditions like Hashimoto’s thyroiditis, rheumatoid arthritis, or multiple sclerosis, the immune system makes a mistake and starts attacking the body’s own tissues. LDN is thought to help by gently modulating this faulty immune response.

By encouraging the production of endorphins, which play a key role in regulating immune function, LDN can help to quieten the ‘attack’ signals. It doesn’t switch the immune system off like some conventional treatments; instead, it coaxes it back towards a healthier equilibrium. This makes it an appealing option for people looking to manage their condition with fewer side effects.

The table below gives a quick summary of how LDN’s proposed actions line up with the symptoms of these key conditions.

Potential applications for low dose naltrexone

This table breaks down how LDN is thought to work for some of the main conditions it’s used for, connecting the symptoms to its proposed biological effects.

Condition	Primary symptoms addressed	Proposed LDN mechanism
Fibromyalgia	Widespread pain, fatigue, brain fog	Increases endorphins to reduce pain sensitivity and calms neuroinflammation from microglial cells.
ME/CFS & Long COVID	Profound fatigue, post-exertional malaise, pain	Modulates the immune system post-infection and reduces the underlying chronic inflammation.
Autoimmune Disorders	Inflammation, pain, fatigue (e.g., Hashimoto’s, MS)	Helps to rebalance the faulty immune response and reduces the inflammatory ‘attack’ on body tissues.

This highlights how a single medicine can have such broad applications by targeting the body’s own regulatory systems.

For many, low dose naltrexone represents a fresh approach. It offers a way to work with the body, providing a gentle nudge back towards balance rather than a forceful intervention.

What the evidence says about LDN

It’s one thing to hear personal success stories, but it’s another to step back and look at the hard science. When it comes to low dose naltrexone, the research landscape is a real mix of excitement and, let’s be honest, a little frustration.

There’s a growing collection of encouraging studies, but we also need to be realistic about where things stand. This section will give you a balanced view of the science behind LDN. We’ll look at what clinical trials are telling us, celebrate the promising findings, and explain why a treatment with so much potential still isn’t a household name.

The goal is to arm you with a clear, realistic perspective, so you can have confident, well-informed conversations with your doctor.

A look at fibromyalgia research

Fibromyalgia is one of the conditions where LDN has been studied the most, and the results have been consistently positive. With an estimated 5% of the UK population grappling with this condition, the need for effective and tolerable treatments is huge [2].

Clinical studies have shown that low dose naltrexone can genuinely reduce the severity of symptoms.

The side effects that were reported were mostly mild things like a dry mouth, and no serious safety issues popped up, even with long-term use. Another study pinpointed that a dose of around 3.88mg was effective for improving ten common fibromyalgia symptoms, leading to a much better quality of life [3].

Promising signs in other conditions

The research doesn’t just stop with fibromyalgia. Several smaller but compelling studies and pilot trials have pointed towards benefits in other areas, including:

• Autoimmune conditions: Studies in Crohn’s disease and multiple sclerosis have suggested that LDN can help calm disease activity and improve people’s day-to-day lives. You might find our dedicated article on the evidence for low dose naltrexone use for multiple sclerosis interesting.
• Chronic pain syndromes: Because of its unique anti-inflammatory action on the central nervous system, it’s become a hot topic for researchers looking into various chronic pain conditions beyond just fibromyalgia.

Even though these studies are often small, they consistently highlight two key things: a very good safety profile and a high level of tolerability. In simple terms, this means most people who try it don’t experience bothersome side effects.

The big question: why isn’t it more widely prescribed?

This is the multi-million-pound question, isn’t it? If LDN is showing so much promise, why aren’t more doctors prescribing it as a first-line treatment? The answer has less to do with how well it works and more to do with the economics of medicine development.

Naltrexone is an old drug. Its patent expired a long, long time ago. This makes it a generic medicine, which is fantastic news for patients because it’s very affordable. But for research, it’s a major roadblock.

Large-scale clinical trials—the kind needed for a drug to become officially licensed for a new use—cost hundreds of millions of pounds. Pharmaceutical companies typically fund these trials, hoping to make a return on their investment when a new, patented drug hits the market.

Because naltrexone is off patent, there’s simply no financial incentive for a big company to pour that kind of money into huge trials for it. This leaves the research in the hands of smaller institutions and independent researchers working with much tighter budgets. The result is an evidence base built on lots of smaller studies rather than a few massive, definitive ones.

This is why low dose naltrexone is primarily prescribed ‘off label’. It’s a recognised treatment, but it’s being used for a purpose other than the one it was originally licensed for. This is a common and perfectly legal practice in medicine. However, it relies on clinicians being up to date with the latest emerging evidence and feeling confident in using pioneering treatments to help their patients find relief.

Navigating LDN dosing and potential side effects

Starting any new medicine can feel a bit daunting, but the journey with low dose naltrexone is designed to be as gentle as possible. The key principle is simple aneffective: ‘start low, go slow’. It’s a careful approach that helps your body adapt comfortably while keeping the risk of side effects to a minimum.

This process, known as titration, means you won’t jump straight to your final dose. Instead, you’ll begin with a tiny amount, often just 0.5mg or 1.5mg, and gradually build up over several weeks. This gives your clinician time to find your personal “sweet spot”—the dose that gives you the most benefit with the fewest issues.

Understanding the titration process

Patience really is your best friend when starting LDN. The slow and steady increase gives your body’s delicate endorphin and immune systems time to adjust to the medication’s gentle nudges. A typical titration plan might involve increasing the dose weekly or fortnightly until you reach a maintenance dose, which for many people is around 4.5mg.

But it’s important to remember there’s no one-size-fits-all dose. Your ideal amount could be higher or lower, and that’s perfectly normal. Working closely with your prescriber is the best way to fine-tune the treatment to your unique needs. If you’re exploring this option, our Low Dose Naltrexone Capsules Starter Pack is specifically designed to make this gradual titration process straightforward.

To give you a clearer idea of what this ‘start low, go slow’ approach looks like in practice, here is a sample titration schedule. This is just an example, and your own plan will be tailored to you by your clinician.

Example LDN titration schedule and side effect tips

Week	Daily dose example	Common side effects	Management tip
1–2	0.5mg to 1.5mg	Vivid dreams, mild headache	Take LDN in the morning. Stay well-hydrated to help with headaches.
3–4	2.0mg to 3.0mg	Sleep disturbances may continue, but often lessen	Stick with morning dosing if sleep is affected. Practice good sleep hygiene (dark room, no screens).
5–6	4.5mg	Mild, temporary nausea	Try taking the capsule with a small, plain snack. The feeling usually passes within a few days.
7+	4.5mg	Side effects have usually faded. Focus on benefits.	If any issues persist, speak to your prescriber. The dose can be adjusted down to find your comfort level.

This table shows how a gradual increase allows your body to adapt. Most side effects are mild and short-lived, often resolving on their own as you get used to the medication.

Common and mild side effects

One of the best things about LDN is its excellent safety profile. Most people tolerate it very well. When side effects do pop up, they are usually mild and temporary, often fading as your body adjusts.

The most frequently mentioned side effects include:

• Vivid dreams or sleep disturbances: This is probably the most common initial side effect. LDN is often taken at night to align with the body’s natural endorphin rhythm, which can sometimes make dreams more intense.
• Headaches: Some people get mild headaches when they first start or increase their dose.
• Nausea: A small number of people might feel a bit queasy, but this nearly always settles down quickly.

A simple but effective tip for managing sleep disturbances is to switch to morning dosing. Taking your LDN when you wake up can often resolve vivid dreams or insomnia without affecting the treatment’s benefits.

Who should not take low dose naltrexone?

While LDN is very safe for most people, it’s not the right choice for everyone. There are a few important situations where it should be avoided.

You should not take LDN if you are:

• Currently taking opioid-based painkillers: This is the most important rule. Because naltrexone blocks opioid receptors, taking it with medicines like codeine, tramadol, or morphine can trigger sudden and severe withdrawal symptoms.
• Pregnant or breastfeeding: There isn’t enough research yet to confirm its safety during pregnancy or while breastfeeding, so it’s best avoided.
• Diagnosed with acute liver disease: Your clinician will check your liver function to make sure it’s safe for you to take the medication.

Before you start, it’s vital to give your clinician a complete list of every medicine and supplement you take. This helps ensure your treatment plan is both safe and effective, giving you the confidence to start your LDN journey on the right foot.

How to access low dose naltrexone in the UK

This is the big question for many people in the UK who are curious about the potential of low dose naltrexone. Trying to figure out the pathways to a prescription can feel like navigating a maze, but it’s actually much simpler once you understand the different routes.

Here, we’ll map out how you can access LDN, explaining why it’s usually prescribed ‘off-label’ and what that really means for you.

The NHS pathway and its challenges

Getting a prescription for low dose naltrexone through the NHS can be tricky, although not completely impossible. The main hurdle is its ‘off label’ status. All this means is that it’s being prescribed for a condition other than the one it was originally licensed for – in this case, opioid and alcohol dependence.

Prescribing off label is a common and perfectly legal practice, but many GPs are understandably cautious. They tend to stick to treatments recommended in the National Institute for Health and Care Excellence (NICE) guidelines. Because LDN hasn’t had the huge, expensive clinical trials needed for a NICE recommendation, GPs often feel they lack the evidence or specialist knowledge to prescribe it with confidence.

It’s quite common to find your GP is unfamiliar with LDN or hesitant to take on the clinical responsibility for an off-label prescription. This isn’t a reflection on their quality of care, but more about the constraints of the NHS system.

Private specialists: a more direct route

This is where private healthcare services, like Medical Mojo, come in to bridge the gap. Private clinicians often have more flexibility and specialised experience with emerging treatments like LDN. They are usually well-versed in the latest evidence and are comfortable managing off-label prescriptions for conditions like fibromyalgia, ME/CFS, and long COVID.

Choosing a private route has some clear advantages:

• Expert knowledge: You’ll be speaking with a clinician who has specific, practical experience in prescribing and monitoring LDN.
• Faster access: You can often bypass long waiting lists and get a timely assessment to see if LDN is a good fit for you.
• Personalised care: The entire focus is on creating a tailored treatment plan, which includes the careful, gradual dose adjustments essential for LDN.

This pathway offers a straightforward and supportive way to explore a treatment that might otherwise be difficult to access.

The crucial role of the compounding pharmacy

Once you have a prescription, there’s one more vital piece of the puzzle: the compounding pharmacy. Standard naltrexone comes in 50mg tablets, which is far too high for an LDN protocol. You can’t just break these tablets up, as it’s impossible to get an accurate and consistent low dose that way.

This means your low dose naltrexone must be specially prepared by a compounding pharmacy. These specialist pharmacies have the equipment and expertise to create precise, custom-dosed capsules, often starting as low as 0.5mg or 1.5mg. They use pure naltrexone powder and mix it with an inactive filler to ensure every single capsule has the exact dose you need.

This bespoke process is vital for both the safety and effectiveness of your treatment. It allows for the slow, steady dose changes that are key to finding what works for you.

How Medical Mojo makes it simple and safe

At Medical Mojo, we’ve built our service to make this entire process as seamless, safe, and stress-free as possible. We handle every step, connecting you with the expertise you need without the usual hurdles.

Our regulated and straightforward process works like this:

1. An in-depth online consultation: You start by completing a thorough online questionnaire, which is reviewed by one of our GPhC-registered clinical professionals.
2. A personalised prescription: If LDN is considered a suitable and safe option for you, our clinician will issue a private prescription tailored to your specific needs.
3. Expert compounding: We work directly with a trusted UK compounding pharmacy that prepares your medication to the highest quality and safety standards.
4. Discreet and prompt delivery: Your personalised LDN is delivered directly and discreetly to your door, ready for you to start your treatment with confidence.

We ensure every part of the process follows the highest medical standards, which you can read more about in our guide on how we source safe medicines. Our goal is to remove the barriers, providing a clear and supportive path to accessing innovative treatments like low dose naltrexone.

LDN FAQs

We get a lot of questions about low dose naltrexone, and it’s completely understandable. Starting any new treatment path comes with a healthy dose of curiosity. To help, we’ve put together some straightforward answers to the most common queries we hear.

How long does it take to work?

This is the big question, and the most honest answer is: it varies from person to person. With LDN, patience really is a virtue. Some people feel subtle shifts in things like pain or sleep quality within a few weeks, but it’s far more common for the benefits to build up slowly over time.

Because LDN works by gently nudging your body’s own systems back into balance, it’s not a quick fix. Think of it more like a gradual restoration project than an overnight repair. You’re most likely to see the biggest changes after two to three months of taking it consistently.

Is LDN safe for long-term use?

One of the most reassuring things about low dose naltrexone is its excellent safety profile. It’s generally considered very safe for long-term use, and studies have consistently shown it to be well-tolerated by most people who take it [4].

Any side effects are usually mild and short-lived, like vivid dreams or headaches, and they often disappear as your body gets used to the medication. Compared to many other drugs used for chronic pain and autoimmune conditions, LDN has a remarkably gentle profile. Of course, it’s always important to have regular check-ins with your clinician to monitor how you’re getting on.

What are the main drug interactions I need to know about?

The most critical one—and this is a non-negotiable—is with opioid-based medications. Because naltrexone is an opioid blocker, taking it with drugs like codeine, tramadol, morphine, or buprenorphine will trigger sudden and severe withdrawal symptoms. You absolutely must stop all opioid medications for a safe period before starting LDN.

It’s vital that you give your clinician a complete and honest list of every medication and supplement you take. This is the only way to make sure your LDN treatment is both safe and effective, and to avoid any potentially harmful interactions.

Beyond opioids, it’s also a good idea to discuss any other medications that affect your immune system. Your prescribing clinician will go through your full medical history to create a safe, personalised plan, giving you peace of mind as you start your journey with LDN.

So, where do you go from here?

Feeling a bit more clued up, and maybe even a little hopeful? You’ve just taken a deep dive into the world of low dose naltrexone—a unique medicine that offers a gentle but potentially powerful way to manage complex chronic conditions. From its clever biological trick of boosting your body’s own endorphins to calming down an overactive immune system, LDN really does represent a different way of thinking about long-term health.

We’ve seen how it might offer a lifeline for conditions like fibromyalgia, ME/CFS, and long COVID. It doesn’t just paper over the cracks by masking symptoms; it works by helping to rebalance the very systems that have gone awry. If there’s one thing to take away, it’s this: LDN is a well-tolerated, off-label treatment that absolutely requires expert medical guidance to be used safely and effectively.

Taking control with Medical Mojo

If you think low dose naltrexone could be a piece of your puzzle, taking the next step is straightforward and completely confidential. At Medical Mojo, we’ve built a seamless process to connect you with specialist care, all from the comfort of your own home. We believe managing your health should feel empowering, not like another uphill battle.

Our simple pathway involves:

• A detailed online consultation: You’ll start by filling out our thorough health questionnaire. This gives our clinicians a full picture of your health journey and your needs.
• Expert clinical review: A qualified, UK-based clinician will personally and carefully review your information to decide if LDN is a safe and suitable option for you.
• A personalised treatment plan: If you’re approved, you’ll receive a tailored treatment plan, and your medication will be delivered discreetly to your door.

More than just a prescription

When you start your journey with us, you’re not just getting a prescription; you’re joining a supportive ecosystem designed to help you thrive. Alongside your personalised medicine, you’ll get access to our evidence-based health guides and have the option of dedicated health coaching. We’re with you at every stage, providing the tools and expertise you need to feel your best.

It’s time to move from endlessly searching for answers to taking meaningful action. Your health journey is yours alone, and you deserve a partner who truly gets that. We’re here to provide a clear, safe, and supportive path forward.

Ready to find out if LDN is right for you? Start your free online consultation today and discover how Medical Mojo can help you take the next confident step on your health journey.

If you found this guide helpful, please share it or bookmark it for later. Your support helps us empower more people with trustworthy health information.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice.

How this content was created: This article was written by our in-house team of health writers and reviewed for clinical accuracy by our qualified prescribers. The information is based on current, evidence-based research from peer-reviewed journals and UK health authorities. We also incorporate anonymised insights from patient experiences to ensure our content is relatable and practical.

References

1. O’Kelly, B., et al. (2024). Available at Full article: Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
2. Available at: Chronic Pain Statistics UK 2025: Prevalence & Trends – Analgesia
3. Metyas, S., et al. (2020) Available at. Low Dose Naltrexone in the Treatment of Fibromyalgia | Bentham Science Publishers
4. Younger, J., Parkitny, L. and McLain, D. (2014) Available at: The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain | Clinical Rheumatology | Springer Nature Link